Futaba (Japan)
In research, Futaba (Japan) stands highest in Medicine (#6,307 of 8,541 worldwide) and Health Sciences (#7,677 of 9,902 worldwide), 2022-now.
- World rank, 2022-now
- #15,765 of 22,385 · #16,346 all time
- Rank in Japan
- #463 of 924
- Research works
- 1.2k ▲ 22% vs 2018-21
- Citations
- 24k 19.5 per fractional work
- Top-10% rate
- 9.9% all institutions 10.0%
- vs its own fields
- 0.98× 1.00× is exactly expected
- Open access
- 46% world 40%
- International
- 10% world 18%
What is Futaba (Japan) known for in research?
The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #6,307 of 8,541 | 11.9% | 66 | #7994 | |
| Health SciencesDomain | #7,677 of 9,902 | 11.8% | 70 | #9450 |
Each strip is that field's whole ranked pool, with the notch where Futaba (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which fields of science does Futaba (Japan) work in?
In 2022-now, 42% of research at Futaba (Japan) is in Health Sciences, 29% in Physical Sciences. Its largest fields are Medicine (40%), Biochemistry, Genetics and Molecular Biology (12%), Engineering (10%). It does 1.8× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 26 fields, with their numbers
- Health Sciences7742.4%
- Medicine7239.8%
- Health Professions31.9%
- Nursing10.4%
- Veterinary00.2%
- Dentistry00.1%
- Physical Sciences5228.7%
- Engineering1810.1%
- Chemistry94.9%
- Materials Science63.4%
- Physics and Astronomy63.2%
- Computer Science52.9%
- Environmental Science52.8%
- Earth and Planetary Sciences10.7%
- Chemical Engineering10.3%
- Mathematics00.3%
- Energy00.1%
- Life Sciences4625.2%
- Social Sciences73.8%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.3×. Every wedge is a field page.
All 26 fields, with their numbers
- Pharmacology, Toxicology and Pharmaceutics9.35×6 works
- Immunology and Microbiology3.90×7 works
- Chemistry3.10×9 works
- Biochemistry, Genetics and Molecular Biology2.34×23 works
- Neuroscience2.16×6 works
- Medicine2.07×72 works
- Veterinary1.47×0 works
- Physics and Astronomy1.46×6 works
- Materials Science0.99×6 works
- Chemical Engineering0.96×1 works
- Nursing0.81×1 works
- Health Professions0.73×4 works
- Engineering0.67×18 works
- Environmental Science0.56×5 works
- Earth and Planetary Sciences0.42×1 works
- Agricultural and Biological Sciences0.41×4 works
- Decision Sciences0.38×1 works
- Computer Science0.37×5 works
- Psychology0.37×2 works
- Mathematics0.23×0 works
- Dentistry0.18×0 works
- Arts and Humanities0.15×1 works
- Energy0.12×0 works
- Social Sciences0.12×3 works
- Business, Management and Accounting0.07×0 works
- Economics, Econometrics and Finance0.03×0 works
- Pharmacology, Toxicology and Pharmaceutics 9.3×
- Immunology and Microbiology 3.9×
- Chemistry 3.1×
- Biochemistry, Genetics and Molecular Biology 2.3×
- Neuroscience 2.2×
- Medicine 2.1×
- Veterinary 1.5×
- Physics and Astronomy 1.5×
- Materials Science 1.0×
- Chemical Engineering 1.0×
- Nursing 0.8×
- Health Professions 0.7×
- Engineering 0.7×
- Environmental Science 0.6×
- Earth and Planetary Sciences 0.4×
- Agricultural and Biological Sciences 0.4×
- Decision Sciences 0.4×
- Computer Science 0.4×
- Psychology 0.4×
- Mathematics 0.2×
- Dentistry 0.2×
- Arts and Humanities 0.1×
- Energy 0.1×
- Social Sciences 0.1×
- Business, Management and Accounting 0.1×
- Economics, Econometrics and Finance 0.0×
Who are the top researchers at Futaba (Japan)?
Ranked on the quality score, Yuki Tachibana, Shota Uehara and Norihiko Tánimoto lead among researchers whose main affiliation is Futaba (Japan).
- 1
Yuki Tachibana
Japan · #2,194,578 worldwide 1.7k citations · 57 works
- 2
Shota Uehara
Japan · #2,315,186 worldwide 911 citations · 23 works
- 3
Norihiko Tánimoto
Japan · #2,400,189 worldwide 634 citations · 21 works
- 4
Yuka Iwamoto
Japan · #2,725,888 worldwide 821 citations · 24 works
- 5
Keiji Dohi
Japan · #3,504,418 worldwide 692 citations · 26 works
- 6
Ken‐ichi Kusakabe
Japan · #3,584,013 worldwide 1.1k citations · 66 works
- 7
Yasuto Kido
Japan · #3,601,436 worldwide 1.4k citations · 38 works
- 8
Takeshi Tonegawa
Japan · #3,828,291 worldwide 460 citations · 24 works
- 9
Shigeo Itoh
Japan · #3,923,365 worldwide 1k citations · 52 works
- 10
Yuji Morikawa
Japan · #4,064,045 worldwide 696 citations · 29 works
Which keywords describe research at Futaba (Japan)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Pandemic, SARS-CoV-2, Vaccine, ACE2 Receptor, Coronavirus, Epidemiology, Immunity and Viral Transmission.
- Virtual Screening
- Drug Target Identification
- Metabolic Regulation
- Antiretroviral Therapy
- Nuclear Receptors
- Molecular Docking
- Droplet Formation
- Drug Resistance
- Cytokine Storm
- Thrombosis
- Multidrug-Resistant Bacteria
- Pathogenesis
- Pharmacokinetics
- Oxidative Stress
- Immune Response
- antibody
- Viral Transmission
- Coronavirus
- Vaccine
- Pandemic
- Epidemiology
- SARS-CoV-2
- ACE2 Receptor
- Immunity
- Antibiotic Resistance
- spike protein
- Inflammation
- Drug Discovery
- Medicinal Chemistry
- ESKAPE Pathogens
- Pathophysiology
- Clinical Characteristics
- Magnetic Resonance Imaging
- Innate Immunity
- Microfluidics
- Neuroinflammation
- Antimicrobial Resistance
- Coronary Artery Disease
- Antibodies
- Multidrug Resistance
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology17▲ 2.3×46 topics
- Pandemic14▲ 7.7×6 topics
- SARS-CoV-212▲ 22×4 topics
- Vaccine12▲ 16×9 topics
- ACE2 Receptor11▲ 26×2 topics
- Coronavirus10▲ 27×3 topics
- Immunity9▲ 13×6 topics
- Viral Transmission9▲ 34×3 topics
- Antibiotic Resistance7▲ 10×8 topics
- antibody7▲ 41×1 topic
- spike protein7▲ 41×1 topic
- Immune Response7▲ 6.8×14 topics
- Inflammation7▲ 1.80×37 topics
- Oxidative Stress6▲ 1.85×20 topics
- Drug Discovery5▲ 12×6 topics
- Pharmacokinetics5▲ 9.8×5 topics
- Medicinal Chemistry4▲ 9.3×7 topics
- Pathogenesis4▲ 4.8×11 topics
- ESKAPE Pathogens4▲ 38×1 topic
- Multidrug-Resistant Bacteria4▲ 38×1 topic
- Pathophysiology4▲ 6.8×3 topics
- Thrombosis4▲ 7.3×4 topics
- Clinical Characteristics3▲ 15×1 topic
- Cytokine Storm3▲ 18×1 topic
- Magnetic Resonance Imaging3▲ 7.1×4 topics
- Drug Resistance3▲ 5.9×5 topics
- Innate Immunity3▲ 5.3×6 topics
- Droplet Formation3▲ 45×1 topic
- Microfluidics3▲ 23×1 topic
- Molecular Docking3▲ 13×2 topics
- Neuroinflammation3▲ 5.3×4 topics
- Nuclear Receptors3▲ 17×2 topics
- Antimicrobial Resistance2▲ 6.6×4 topics
- Antiretroviral Therapy2▲ 7.9×4 topics
- Coronary Artery Disease2▲ 12×2 topics
- Metabolic Regulation2▲ 8.0×3 topics
- Antibodies2▲ 22×2 topics
- Drug Target Identification2▲ 14×1 topic
- Multidrug Resistance2▲ 38×2 topics
- Virtual Screening2▲ 14×1 topic
Which research topics does Futaba (Japan) publish most on?
By volume in 2022-now: SARS-CoV-2 and COVID-19 Research, Antibiotic Resistance in Bacteria, COVID-19 Clinical Research Studies and Innovative Microfluidic and Catalytic Techniques Innovation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 7 works
- 2 Antibiotic Resistance in Bacteria Molecular Medicine 4 works
- 3 COVID-19 Clinical Research Studies Infectious Diseases 3 works
- 4 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 3 works
- 5 Computational Drug Discovery Methods Computational Theory and Mathematics 2 works
- 6 Radiation Detection and Scintillator Technologies Radiation 2 works
- 7 Antibiotics Pharmacokinetics and Efficacy Pharmacology 2 works
- 8 Chemical Synthesis and Analysis Molecular Biology 2 works
- 9 Cardiac Imaging and Diagnostics Radiology, Nuclear Medicine and Imaging 2 works
- 10 Drug Transport and Resistance Mechanisms Oncology 2 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Futaba (Japan)'s research output changed?
Output in 2022-2025 was 22% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Futaba (Japan) as a percentage of every work published that year, 0.00074% in 2024.
Fractional works of Futaba (Japan) over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 14.7% in 2018.
Other research institutions in Mobara
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Futaba (Japan). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
